Undiagnosed diabetes, impaired renal function, and certain drug interactions can only be identified through laboratory testing
Lipoprotein a (Lp(a)) is a useful predictor of cardiovascular disease
What if semaglutide isnt right for me
The Phase 2 combination trial in type 2 diabetes reported that, by its 32-week endpoint, the cagrilintide-plus-semaglutide arm reached 15.6% mean weight loss versus 8.1% for cagrilintide alone and 5.1% for semaglutide alone with the combination curve already diverging upward through the early months (Frias et al., 2023)
Proving it out through in-club MIORA clinics, Life Time pairs prescriptions with diagnostics, nutrition, strength training, and coaching, positioning health clubs as a critical complement to treatment